secwatch / observer
8-K filed February 14, 2025, 6:59 PM ET ticker BNTC CIK 0001808898
earnings confidence high sentiment neutral materiality 0.60

Benitec Biopharma reports Q2 FY2025 net loss of $7.4M, cash at $78.3M; five patients treated with BB-301 in Phase 1b/2a

Benitec Biopharma Inc.

2024-Q2 EPS reported -$0.76
item 2.02item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-25-026659
form_type
8-K
ticker
BNTC
cik
0001808898
company_name
Benitec Biopharma Inc.
filed_at
2025-02-14T23:59:59+00:00
discovered_at
2026-05-14T18:03:04.965785+00:00
generated_at
2026-05-26T21:32:22.092528+00:00
sec_items
["2.02", "9.01"]
event_type
earnings
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-25-026659
json_url
https://secwatch.observer/filing/0001193125-25-026659.json
markdown_url
https://secwatch.observer/filing/0001193125-25-026659.md
text_url
https://secwatch.observer/filing/0001193125-25-026659.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1808898/000119312525026659/0001193125-25-026659-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1808898/000119312525026659/d877190d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

DAVEY TREE EXPERT CO

Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M

DAVEY TREE EXPERT CO June 1, 2026, 1:50 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BKE

Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M

BUCKLE INC May 29, 2026, 3:38 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HIND

Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis

Vyome Holdings, Inc May 29, 2026, 8:42 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PKE

Park Aerospace Q4 sales up 43% to $24.2M; EPS $0.19 vs $0.06 YoY; full-year net earnings double to $11.3M

PARK AEROSPACE CORP May 28, 2026, 4:29 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

GAP

Gap Inc. Q1 net sales up 1% to $3.5B; adj. EPS $0.38; raises full-year EPS outlook

GAP INC May 28, 2026, 4:16 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

PD

PagerDuty Q1 revenue $121M up 1% YoY; new CEO DiLullo; $100M buyback

PagerDuty, Inc. May 28, 2026, 4:07 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

RICK

RCI Hospitality posts Q2 GAAP loss of $0.04 on $7.6M impairment; non-GAAP EPS rises to $0.78

RCI HOSPITALITY HOLDINGS, INC. May 28, 2026, 4:07 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

NTAP

NetApp reports Q4/FY2026 results (details not in filing) and adds $1B buyback

NetApp, Inc. May 28, 2026, 4:05 PM ET earnings Items 2.02, 8.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-25-026659
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.